A study analyzing inammation which prevails after treatment with anti-IL-5/5R α biologicals
Latest Information Update: 11 Apr 2022
At a glance
- Drugs Benralizumab (Primary) ; Mepolizumab (Primary) ; Anti-interleukin-5 monoclonal antibody
- Indications Nasal polyps
- Focus Pharmacodynamics
Most Recent Events
- 11 Apr 2022 New trial record
- 28 Feb 2022 Results presented at the 2022 Annual Meeting of the American Academy of Allergy, Asthma and Immunology